Keywords: novartis, exjade, approved, scotland, swiss, drug, major

Novartis' Exjade approved in Scotland

Article | 19 February 2007

Swiss drug major Novartis' once-daily iron chelator Exjade (deferasirox) has been approved by the Scottish Medicines Consortium for the treatment ...

Enjoying this article? To continue reading you need to login or subscribe.

Subscribe now
for unlimited access to all articles

Subscriptions are £60 per month, pay as you go.
Find out more details.

Already a subscriber? Click here to log in

Related Companies

Novartis

Go to company listing

Related Drugs

Deferasirox

Exjade

Go to drug listing